Brevan Howard Capital Management’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$573K	Sell	113,198 -143,803	-56%	-$728K	﹤0.01%	1214
2025 Q1	$1.36M	Buy	257,001 +216,910	+541%	+$1.15M	0.01%	357
2024 Q4	$271K	Buy	+40,091	New	+$271K	﹤0.01%	784
2024 Q2	–	Sell	-21,096	Closed	-$210K	–	1307
2024 Q1	$210K	Buy	+21,096	New	+$210K	﹤0.01%	736